Capsaicin
Active ingredient · 2 therapeutic classes
Sold as Qutenza · Capsadyn · Satogesic Hot · CAPSINA · Trubrexa Patch ER
- Drug class
- Other Local Anesthetics
- Availability
- Prescription and OTC
- Routes
- Topical, Transdermal
- Markets covered
- 3
- Products on record
- 22
- FDA reports (12 mo)
- 657
Overview
Capsaicin is an active pharmaceutical ingredient in the Other Local Anesthetics group (N01BX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 15 | May 7, 2026 |
| GB United Kingdom | MHRA | 6 | May 29, 2026 |
| EU European Union | EMA | 1 | May 5, 2026 |
USUnited States· FDA
15 products
Uses
Uses Temporarily relieves minor aches and pains of muscles and joints due to: • simple backache • arthritis • strains • sprains
How to take
GBUnited Kingdom· MHRA
6 products
Uses
1. For the symptomatic relief of neuralgia associated with and following Herpes Zoster infections (post-herpetic neuralgia) after open skin lesions have healed. 2. For the symptomatic management of painful diabetic peripheral polyneuropathy.
How to take
EUEuropean Union· EMA
1 product
Uses
Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for the treatment of pain.
How to take
Drug interactions
Known interactions involving Capsaicin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 0090ca38-6433-45… · revised December 6, 2024 [PDF]
- [2]MHRA (UK) · PL556120090 · revised May 1, 2026
- [3]European Medicines Agency · EMEA/H/C/000909 · revised May 5, 2026
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.